07 Aug 2013, BioSpectrum Bureau , BioSpectrum
Singapore: Sinopharm Group is going to build China's largest Biotechnology Research Institute in Wuhan East Lake High-tech Zone. The facility will showcase all of Sinopharm's existing biotech R&D resources under one roof.
The facility will be part of a Sinopharm subsidiary, the China Institute of Pharmaceutical Industry. Sinopharm highlighted that the institute will comprise of two-to-three separate buildings and will be constructed in a period of three years.